|
My Mom had a HER2/neu+3 mass removed about a year ago. During surgery, the surgeon decided (despite my request) to avoid doing a sentinel node mapping/removal. Only one node (enlarged) was removed, and found to be clear. No further treatment was recommended.
Then came the surprise HER2+ status from pathology. I proceded to get her radiation therapy, as I feared the unknown status of the remaining axillary nodes, and wanted to prevent a recurrence at all cost. I asked the oncologist if she could receive Herceptin to be safe. He said she didn't qualify because she had no evidence of disease. All was well until another enlarged node was found to be positive upon biopsy a few weeks ago. Now she is about to have the axillary dissection she should have had a year ago. I am wondering what chance she has for success with Herceptin as a single agent therapy now. She is not healthy enough to undergo any other type of chemotherapy, but her heart is in pretty good shape for her age.
I am wondering if anyone has any suggestions as to what other therapies/clinical trials might help her now. I'm not ready to lose my Mom just yet.
|
Threaded Mode